Post-ERCP Pancreatitis: Reduction by Routine Antibiotics

Journal of Gastrointestinal Surgery

Volumn 5, Issue 4, 2001, Pages 339-345

  Räty, Sari ^a   Sand, Juhani ^a   Pulkkinen, Markku ^b   Matikainen, Martti ^a   Nordback, Isto ^a  

^a TAMPERE UNIVERSITY HOSPITAL   (Finland)

^b Glaxo Wellcome Pharmaceutical Company   (Finland)

Author keywords

Antibiotics; Post ERCP pancreatitis; Prophylaxis e

Indexed keywords

AMYLASE; CEFTAZIDIME; CEPHALOSPORIN DERIVATIVE;

ACUTE DISEASE; ANTIBIOTIC PROPHYLAXIS; ARTICLE; BLOOD; CHOLANGITIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; FEMALE; HUMAN; MALE; MIDDLE AGED; PANCREATITIS; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR;

ACUTE DISEASE; AMYLASES; ANTIBIOTIC PROPHYLAXIS; CEFTAZIDIME; CEPHALOSPORINS; CHOLANGIOPANCREATOGRAPHY, ENDOSCOPIC RETROGRADE; CHOLANGITIS; FEMALE; HUMANS; MALE; MIDDLE AGED; PANCREATITIS; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 0035412170     PISSN: 1091255X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1091-255X(01)80059-7     Document Type: Article

References (35)

1. Bilbao MK, Dotter CT, Lee TG, Katon RM. Complications of endoscopic retrograde cholangiopancreatography (ERCP): A study of 10,000 cases. Gastroenterology 1976;70:314-320.
2. Loperfido S, Angelini G, Benedetti G, Chilovi F, Costan F, De Berardinis F, De Bernandin M, Ederle A, Fina P, Fratton A Major early complications from diagnostic and therapeutic ERCP: A prospective multicenter study. Gastrointest Endosc 1998;48:1-10.
3. Halme L, Doepel M, von Numers H, Edgren J, Ahonen J. Complications of diagnostic and therapeutic ERCP. Ann Chir Gynaecol 1999;88:127-131.
4. Freeman M, Nelson D, Sherman S, Haber G, Herman M, Dorsher P, Moore J, Fennerty M, Ryan M, Shaw M, Lande J, Pheley A. Complications of endoscopic biliary sphincterotomy. N Engl J Med 1996;335:909-918.
5. Motte S, Deviere J, Dumonceau JM, Serruys E, Thys JP, Cremer M. Risk factors for septicemia following endoscopic biliary stenting. Gastroenterology 1991;101:1374-1381.
6. Brandes JW, Scheffer B, Lorenz-Meyer H, Korst HA, Littmann KP. ERCP: Complications and prophylaxis. A controlled study. Endoscopy 1981;13:27-30.
7. Sauter G, Grabein B, Huber G, Mannes GA, Ruckdeschel G, Sauerbruch T. Antibiotic prophylaxis of infectious complications with endoscopic retrograde cholangiopancreatography. Endoscopy 1990;22:164-167.
8. Alveyn CG, Robertson DAF, Wright R, Lowes JA, Tillotson G. Prevention of sepsis following endoscopic retrograde cholangiopancreatography. J Hosp Infect 1991;19(suppl): C65-C70.
9. Byl B, Deviere J, Struelens M, Roucloux I, Coninck A, Thys JP, Cremer M. Antibiotic prophylaxis for infectious complications after therapeutic endoscopic retrograde cholangiopancreatography: A randomized, double-blind, placebo-controlled study. Clin Infect Dis 1995;20:1236-1240.
10. Niederau C, Pohlmann U, Lubke H, Thomas L. Prophylactic antibiotic treatment in therapeutic or complicated diagnostic ERCP: Results of a randomized controlled clinical study. Gastrointest Endosc 1994;40:533-537.
11. Hazel S, Speelman P, Dankert J, Huibregtse K, Tytgat G, Leeuwen D. Piperacillin to prevent cholangitis after endoscopic retrograde cholangiopancreatography. A randomized controlled study. Ann Intern Med 1996;125:442-447.
12. Davis A, Kolios G, Alveyn C, Robertson D. Antibiotic prophylaxis for ERCP: A comparison of oral ciprofloxacin with intravenous cephazolin in the prophylaxis of high-risk patients. Aliment Pharmacol Ther 1998;12:207-211.
13. Cavallini G, Tittobello A, Frulloni L, Masci E, Mariani A, Di Francesco V. Gabexate for prevention of pancreatic damage related to endoscopic retrograde cholangiopancreatography. N Engl J Med 1996;335:919-923.
14. Sherman S, Lehman GA ERCP- and endoscopic sphincterotomy-induced pancreatitis. Pancreas 1991;6:350-367.
15. Sherman S. ERCP and endoscopic sphincterotomy-induced pancreatitis. Am J Gastroenterol 1994;89:303-305.
16. Nordback I, Airo I. Post-ERCP acute necrotizing pancreatitis. Ann Chir Gynaecol 1988;77:15-20.
17. Keynes WM. The mythology of acute pancreatitis. Infect Surg 1987;6:354-358.
18. Sand J, Airo I, Hiltunen K-M, Mattila J, Nordback I. Changes in biliary bacteria after endoscopic cholangiography and sphincterotomy. Am Surg 1992;58:324-328.
19. Ranson JHC, Pasternack BS. Statistical methods for qualifying the severity of clinical acute pancreatitis. J Surg Res 1977; 22:79-91.
20. Cotton PB, Lehman GA, Vennes J. Endoscopic sphincterotomy complications and their management: An attempt at consensus. Gastrointest Endosc 1991;37:383-393.
21. Hamilton I, Lintott DJ, Rothwell J, Axon AT. Acute pancreatitis following endoscopic retrograde cholangiopancreatography. Clin Radiol 1983;34:543-546.
22. Cunliffe WJ, Cobden I, Lavelle MI, Lendrum R, Tait NP, Venables CW. A randomized prospective study comparing two contrast media in ERCP. Endoscopy 1987;19:201-202.
23. Roszler MH, Campbell WL. Post-ERCP pancreatitis: Association with urographic visualization during ERCP. Radiology 1985;157:595-598.
24. Sherman S, Ruffolo TA, Hawes RH, Lehman GA. Complications of endoscopic sphincterotomy. A prospective series with emphasis on the increased risk associated with sphincter of Oddi dysfunction and nondilatated bile ducts. Gastroenterology 1991;101:1068-1075.
25. Chen YK, Foliente RL, Santoro MJ, Walter MH, Colle MJ. Endoscopic sphincterotomy-induced pancreatitis: Increased risk associated with non-dilated bile ducts and sphincter of Oddi dysfunction. Am J Gastroenterol 1994;89:327-333.
26. Tarnasky P, Cunningham J, Cotton P, Hoffman B, Palesch Y, Freeman J, Curry N, Hawes R. Pancreatic sphincter hypertension increases the risk of post-ERCP pancreatitis. Endoscopy 1997;29:252-257.
27. Laugier R, Bernard JP, Berthezene P, Dupuy P. Changes in pancreatic exocrine secretion with age: Pancreatic exocrine secretion does decrease in the elderly. Digestion 1991;50:202-211.
28. Mehta S, Pavone J, Bouchard S, Barkun S. Predictors of post-ERCP complications in patients with suspected choledocholithiasis. Endoscopy 1998;30:457-463.
29. Binmoeller KF, Harris AG, Dumas R, Grimaldi C, Delmont JP. Does the somatostatin analogue octreotide protect against ERCP-induced pancreatitis? Gut 1992;33:1129-1133.
30. Sand J, Nordback I. Prospective randomized trial of the effect of nifedipine on pancreatic irritation after endoscopic retrograde cholangiopancreatography. Digestion 1993;54:105-111.
31. Palma G, Catanzano C. Use of corticosteroids in the prevention of post-ERCP pancreatitis: Results of a controlled prospective study. Am J Gastroenterol 1999;94:982-985.
32. Poon R, Yeung C, Lo CM, Yuen WK, Liu CL, Fan ST. Prophylactic effect of somatostatin on post-ERCP pancreatitis: A randomized controlled trial. Gastrointest Endosc 1999;49: 593-598.
33. Araida T, Frey C, Ruebner B, Carlson J, King J. Therapeutic regimens in acute experimental pancreatitis in rats: Effects of a protease inhibitor, a β-agonist, and antibiotics. Pancreas 1995;11:132-140.
34. Toosie A, Chang L, Renslo R, Arnell T, Bongard R, Satbile BE, de Virgilio C. Early computed tomography is rarely necessary in gallstone pancreatitis. Am J Surg 1997;63:904-907.
35. Lin XZ, Wang SS, Tsai YT, Lee SD, Shiesh SC, Pan HB, Su CH, Lin CY. Serum amylase, isoamylase and lipase in the acute abdomen. Their diagnostic value for acute pancreatitis. J Clin Gastroenterol 1989;11:47-52.